PROSTATE CANCER TREATMENT
is the leading provider of Cryotherapy and
High Intensity Focused Ultrasound (HIFU) technology to treat both untreated and
previously treated prostate cancer.
Dr. Kuglitsch is also experienced with treating patients who have rising PSA after radiation treatment.
Prostate Cancer occurs when normal cells change to malignant cells. Prostate cancer is the most common cancer found in men. More than 30,000 cases are detected annually in the U.S. When men turn 40, the risk for Prostate Cancer increases exponentially. It is usually a slow-growing cancer that is found primarily in older men.
However, some prostate cancers are more aggressive, and may affect younger men. Men with a family history of prostate cancer, as well as men of African-American descent are known to be at increased risk for the disease.
A thorough history and physical examination and PSA test are important in detecting prostate cancer. When the PSA or the rectal exam is abnormal, a prostate biopsy is necessary to rule out prostate cancer. An ultrasound probe is placed in the rectum, and small amounts of tissue are sampled.
The pathologist can then make the proper diagnosis. If prostate cancer is identified, the patient undergoes a staging evaluation with blood work and X-rays.
If prostate cancer is identified, the patient undergoes a staging evaluation with blood work and X-rays. Treatment options vary and can include Cryotherapy, HIFU, Outpatient Treatment, Observation, Radiation Therapy, and Surgical Removal.